Your Article Summary
See Latest ArticlesThe Effect of Recombinant Human Erythropoietin on the Development of Retinopathy of Prematurity
American Journal of Perinatology, 06/30/09
Shah N et al. - The study showed there is no significant difference in the incidence and severity of ROP between the rhEPO-treated and nontreated group.
Related Articles
Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin
Haematologica, 10/21/09
Relevance Score: 67%
Down with the Erythropoietin. Long Live the Erythropoietin
Current Drug Targets, 10/23/09
Relevance Score: 65%
Efficacy of preoperative recombinant human erythropoietin administration for reducing transfusion requirements in patients undergoing surgery for hip fracture repair. An observational cohort study
Vox Sanguinis, 10/06/09
Relevance Score: 65%
Recombinant Human Erythropoietin in the Treatment of Acute Ischemic Stroke
Stroke, 10/19/09
Relevance Score: 64%
Antioxidants and other pharmacological treatments for Friedreich ataxia
Cochrane Reviews, 10/09/09
Relevance Score: 63%
Today in Retina...keeping you current
Receive free subspecialty "5-minute updates" via email
Pathophysiology and management of diabetic retinopathy
Expert Review of Ophthalmology, 12/07/09
Treatment of branch retinal vein occlusion
Expert Review of Ophthalmology, 12/07/09
Measurement of quality of life for people with diabetic retinopathy impairment
Expert Review of Ophthalmology, 12/07/09